Decreased hippocampal 5-HT2A receptor binding in older depressed patients using [18F] altanserin positron emission tomography

被引:59
作者
Sheline, YI
Mintun, MA
Barch, DM
Wilkins, C
Snyder, AZ
Moerlein, SM
机构
[1] Washington Univ, Sch Med, Dept Psychiat, St Louis, MO 63110 USA
[2] Washington Univ, Sch Med, Dept Radiol, St Louis, MO 63110 USA
[3] Washington Univ, Sch Med, Dept Neurol, St Louis, MO 63110 USA
[4] Washington Univ, Sch Med, Dept Psychol, St Louis, MO USA
[5] Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA
关键词
depression; positron emission tomography (PET); hippocampus; serotonin; 5-HT2A receptors; altanserin;
D O I
10.1038/sj.npp.1300555
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Serotonin receptor changes have been associated with the pathophysiology and treatment of major depression. Only one other study has investigated serotonin receptor changes in older depressed patients. We used positron emission tomography ( PET) and [F-18] altanserin, a ligand with high affinity for the 5-HT2A receptor, to examine the relationship between 5-HT2A receptor density and depression. Depressed subjects ( n = 16), age >50 years, were recruited as part of a larger study. Older depressed subjects consisted of early-onset recurrent depression ( EORD, n = 11) and late-onset depression (LOD, n = 5). An age-matched control group ( n = 9) was also recruited. All subjects were right-handed, nonsmokers and antidepressant-free. Regions of interest were determined on a summed MPRAGE scan transformed into Talairach space and coregistered with the PET images. Depressed subjects had less hippocampal 5-HT2A receptor binding than controls ( p = 0.05). No significant differences in receptor binding were found between EORD and LOD subjects. Depressed subjects not previously treated for depression ( n = 6) had less hippocampal 5-HT2A receptor binding (p = 0.04) than previously treated subjects ( n = 10). It may be that prior medication treatment provides a compensatory upregulation of the 5-HT2A receptor.
引用
收藏
页码:2235 / 2241
页数:7
相关论文
共 42 条
[1]   The cortical serotonin2 receptors studied with positron-emission tomography and [18F]-setoperone during depressive illness and antidepressant treatment with clomipramine [J].
Attar-Lévy, D ;
Martinot, JL ;
Blin, J ;
Dao-Castellana, MH ;
Crouzel, C ;
Mazoyer, B ;
Poirier, MF ;
Bourdel, MC ;
Aymard, N ;
Syrota, A ;
Féline, A .
BIOLOGICAL PSYCHIATRY, 1999, 45 (02) :180-186
[2]   AGE-OF-ONSET AND GENETIC TRANSMISSION IN AFFECTIVE-DISORDERS [J].
BARON, M ;
MENDLEWICZ, J ;
KLOTZ, J .
ACTA PSYCHIATRICA SCANDINAVICA, 1981, 64 (05) :373-380
[3]   Brain morphometric abnormalities in geriatric depression: long-term neurobiological effects of illness duration [J].
Bell-McGinty, S ;
Butters, MA ;
Meltzer, CC ;
Greer, PJ ;
Reynolds, CF ;
Becker, JT .
AMERICAN JOURNAL OF PSYCHIATRY, 2002, 159 (08) :1424-1427
[4]   In vivo binding of [F-18]altanserin to rat brain 5HT(2) receptors: A film and electronic autoradiographic study [J].
Biver, F ;
Lotstra, F ;
Monclus, M ;
Dethy, S ;
Damhaut, P ;
Wikler, D ;
Luxen, A ;
Goldman, S .
NUCLEAR MEDICINE AND BIOLOGY, 1997, 24 (04) :357-360
[5]   Serotonin 5-HT2 receptor imaging in major depression: focal changes in orbito-insular cortex [J].
Biver, F ;
Wikler, D ;
Lotstra, F ;
Damhaut, P ;
Goldman, S ;
Mendlewicz, J .
BRITISH JOURNAL OF PSYCHIATRY, 1997, 171 :444-448
[6]   Hippocampal volume reduction in major depression [J].
Bremner, JD ;
Narayan, M ;
Anderson, ER ;
Staib, LH ;
Miller, HL ;
Charney, DS .
AMERICAN JOURNAL OF PSYCHIATRY, 2000, 157 (01) :115-117
[7]   PHYSIOPHARMACOLOGICAL INTERACTIONS BETWEEN STRESS HORMONES AND CENTRAL SEROTONERGIC SYSTEMS [J].
CHAOULOFF, F .
BRAIN RESEARCH REVIEWS, 1993, 18 (01) :1-32
[8]  
CHARNEY DS, 1981, ARCH GEN PSYCHIAT, V38, P1160
[9]   BRAIN 5-HT2 RECEPTOR-BINDING SITES IN DEPRESSED SUICIDE VICTIMS [J].
CHEETHAM, SC ;
CROMPTON, MR ;
KATONA, CLE ;
HORTON, RW .
BRAIN RESEARCH, 1988, 443 (1-2) :272-280
[10]   NEUROTRANSMITTER RECEPTORS AND MONOAMINE METABOLITES IN THE BRAINS OF PATIENTS WITH ALZHEIMER-TYPE DEMENTIA AND DEPRESSION, AND SUICIDES [J].
CROW, TJ ;
CROSS, AJ ;
COOPER, SJ ;
DEAKIN, JFW ;
FERRIER, IN ;
JOHNSON, JA ;
JOSEPH, MH ;
OWEN, F ;
POULTER, M ;
LOFTHOUSE, R ;
CORSELLIS, JAN ;
CHAMBERS, DR ;
BLESSED, G ;
PERRY, EK ;
PERRY, RH ;
TOMLINSON, BE .
NEUROPHARMACOLOGY, 1984, 23 :1561-1569